Cdk Associates, L.l.c. - Net Worth and Insider Trading
Cdk Associates, L.l.c. Net Worth
The estimated net worth of Cdk Associates, L.l.c. is at least $16 Million dollars as of 2024-05-10. Cdk Associates, L.l.c. is the 10% Owner of Strongbridge Biopharma PLC and owns about 8,060,682 shares of Strongbridge Biopharma PLC (SBBP) stock worth over $16 Million. Cdk Associates, L.l.c. is the Director of Molecular Templates Inc and owns about 105,616 shares of Molecular Templates Inc (MTEM) stock worth over $156,312. Cdk Associates, L.l.c. is also the 10% Owner of Kala Bio Inc and owns about 4,300 shares of Kala Bio Inc (KALA) stock worth over $29,670. Details can be seen in Cdk Associates, L.l.c.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Cdk Associates, L.l.c. has not made any transactions after 2020-09-18 and currently still holds the listed stock(s).
Transaction Summary of Cdk Associates, L.l.c.
Cdk Associates, L.l.c. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Cdk Associates, L.l.c. owns 4 companies in total, including Strongbridge Biopharma PLC (SBBP) , Molecular Templates Inc (MTEM) , and Kala Bio Inc (KALA) among others .
Click here to see the complete history of Cdk Associates, L.l.c.’s form 4 insider trades.
Insider Ownership Summary of Cdk Associates, L.l.c.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SBBP | Strongbridge Biopharma PLC | 2020-09-18 | 10 percent owner |
| MTEM | Molecular Templates Inc | 2018-12-26 | director |
| KALA | Kala Bio Inc | 2017-07-20 | 10 percent owner |
 | | 2016-07-12 | other: See Remarks Section |
Cdk Associates, L.l.c. Latest Holdings Summary
Cdk Associates, L.l.c. currently owns a total of 3 stocks. Among these stocks, Cdk Associates, L.l.c. owns 8,060,682 shares of Strongbridge Biopharma PLC (SBBP) as of September 18, 2020, with a value of $16 Million and a weighting of 98.86%. Cdk Associates, L.l.c. owns 105,616 shares of Molecular Templates Inc (MTEM) as of December 26, 2018, with a value of $156,312 and a weighting of 0.96%. Cdk Associates, L.l.c. also owns 4,300 shares of Kala Bio Inc (KALA) as of July 20, 2017, with a value of $29,670 and a weighting of 0.18%.
Latest Holdings of Cdk Associates, L.l.c.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SBBP | Strongbridge Biopharma PLC | 2020-09-18 | 8,060,682 | 2.00 | 16,121,364 |
| MTEM | Molecular Templates Inc | 2018-12-26 | 105,616 | 1.48 | 156,312 |
| KALA | Kala Bio Inc | 2017-07-20 | 4,300 | 6.90 | 29,670 |
Holding Weightings of Cdk Associates, L.l.c.
Cdk Associates, L.l.c. Form 4 Trading Tracker
According to the SEC Form 4 filings, Cdk Associates, L.l.c. has made a total of 1 transactions in Strongbridge Biopharma PLC (SBBP) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Strongbridge Biopharma PLC is the acquisition of 1,479,377 shares on September 18, 2020, which cost Cdk Associates, L.l.c. around $3 Million.
According to the SEC Form 4 filings, Cdk Associates, L.l.c. has made a total of 0 transactions in Molecular Templates Inc (MTEM) over the past 5 years. The most-recent trade in Molecular Templates Inc is the acquisition of 1,667 shares on December 26, 2018, which cost Cdk Associates, L.l.c. around $86,250.
According to the SEC Form 4 filings, Cdk Associates, L.l.c. has made a total of 0 transactions in Kala Bio Inc (KALA) over the past 5 years. The most-recent trade in Kala Bio Inc is the acquisition of 4,300 shares on July 20, 2017, which cost Cdk Associates, L.l.c. around $3 Million.
Insider Trading History of Cdk Associates, L.l.c.
- 1
Cdk Associates, L.l.c. Trading Performance
GuruFocus tracks the stock performance after each of Cdk Associates, L.l.c.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Cdk Associates, L.l.c. is 6.12%. GuruFocus also compares Cdk Associates, L.l.c.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Cdk Associates, L.l.c. within 3 months outperforms 6 times out of 12 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Cdk Associates, L.l.c.'s insider trading performs compared to the benchmark.
Performance of Cdk Associates, L.l.c.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 11.52 | | | | | |
| Relative Return to S&P 500(%) | 8.63 | | | | | |
Cdk Associates, L.l.c. Ownership Network
Cdk Associates, L.l.c. Owned Company Details
What does Strongbridge Biopharma PLC do?
Who are the key executives at Strongbridge Biopharma PLC?
Cdk Associates, L.l.c. is the 10 percent owner of Strongbridge Biopharma PLC. Other key executives at Strongbridge Biopharma PLC include 10 percent owner Caxton Corp , 10 percent owner Bruce Kovner , and director & Chief Executive Officer John Johnson .
Strongbridge Biopharma PLC (SBBP) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Strongbridge Biopharma PLC (SBBP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Strongbridge Biopharma PLC (SBBP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Strongbridge Biopharma PLC (SBBP)'s detailed insider trading history can be found in Insider Trading Tracker table.
Strongbridge Biopharma PLC Insider Transactions
Cdk Associates, L.l.c. Mailing Address
Above is the net worth, insider trading, and ownership report for Cdk Associates, L.l.c.. You might contact Cdk Associates, L.l.c. via mailing address: C/o Caxton Corporation, 731 Alexander Road, Building #2, Princeton Nj 08540.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
